Bailard’s Idexx Laboratories IDXX Stock Holding History

Bailard’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.24M	Buy	4,280 +285	+7%	+$156K	0.05%	238
2026 Q2	$2.1M	Buy	3,995 +1,842	+86%	+$1.03M	0.04%	257
2026 Q1	$1.21M	Sell	2,153 -889	-29%	-$570K	0.03%	296
2025 Q4	$2.06M	Buy	3,042 +479	+19%	+$326K	0.05%	226
2025 Q3	$1.64M	Buy	2,563 +615	+32%	+$373K	0.04%	266
2025 Q2	$1.04M	Buy	+1,948	New	+$932K	0.02%	318
2022 Q2	–	Sell	-502	Closed	-$275K	–	736
2022 Q1	$275K	Buy	502 +159	+46%	+$83.6K	0.01%	561
2021 Q4	$226K	Buy	+343	New	+$215K	0.01%	647
2021 Q2	–	Sell	-729	Closed	-$357K	–	726
2021 Q1	$357K	Buy	729 +140	+24%	+$70.1K	0.01%	462
2020 Q4	$294K	Buy	+589	New	+$264K	0.01%	446

Other funds holding IDXX

Montrusco Bolton Investments Montreal, Quebec, Canada $5.77B AUM 24.61% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Seilern Investment Management London, United Kingdom $771M AUM 2.59% 1-Year Est. Return

Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.31B AUM 25.55% 1-Year Est. Return

Mogy Joel R Investment Counsel Beverly Hills, California $1.87B AUM 18.64% 1-Year Est. Return

MIM

Manitou Investment Management Toronto, Ontario, Canada $532M AUM 7.98% 1-Year Est. Return

Chicago Capital Chicago, Illinois $4.32B AUM 31.14% 1-Year Est. Return

Bailard's IDXX Position: Q3 2026 in Review

Bailard increased its Idexx Laboratories (IDXX) stake by 7.1% in Q3 2026, buying an estimated $156K and bringing the position to 4,280 shares worth $2.24M. The position accounts for 0.05% of the portfolio, ranked #238.

Bailard first reported a position in IDXX in Q4 2020 and has held it in 10 quarters since. 215 funds tracked by Wall St. Rank hold IDXX as of Q3 2026.

Bailard held 4,280 shares of Idexx Laboratories worth $2.24M as of Q3 2026.
Bailard bought 285 Idexx Laboratories shares in Q3 2026, an estimated $156K.
Idexx Laboratories made up 0.05% of Bailard's portfolio in Q3 2026, its #238 holding.
Bailard first reported a position in Idexx Laboratories in Q4 2020 and has held it in 10 quarters since.
215 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2026.

Based on Bailard's 13F filing for Q3 2026, filed 13 Oct 2026.